Literature DB >> 16351478

[Herpetic encephalitis in adults: 23 cases].

F J Burón Mediavilla1, J C Rodríguez Borregán, E Miñambres, C González Fernández, A González Castro, M S Holanda Peña, A Quesada Suescun.   

Abstract

OBJECTIVE: To study the clinical presentation, diagnosis, treatment and prognosis of the herpetic encephalitis in our environment. MATERIAL AND
METHOD: During the past 12 years, 23 adults (age > 15 years) were treated for herpetic encephalitis in our centre.
RESULTS: There were 14 males and 9 females. Ages ranged from 18 to 84 years (mean, 52.30 +/- 18.64 years). The hospital stay ranged from 5 to 64 days (mean, 26.74 +/- 15.41 days). Eleven patients were managed in the intensive care unit and nine patients required mechanical ventilation. The most frequent clinical features they were the level of conscience decrease and fever. The lymphocytic pleiocytosis was the most frequent discovery in cerebrospinal fluid. The temporal lobe lesions in the computed tomography scan appeared in 14 patients (61%). Four patients died, seven patients were asymptomatic or with minimum sequels and twelve patients developed they were disabled.
CONCLUSIONS: The herpetic encephalitis is an uncommon illness. Intravenous acyclovir is recommended treatment and the corticosteroids use is controverted. The delay in the treatment beginning worsens the prognosis. Less than a third of the patients achieve the functional independence to discharge hospital.

Entities:  

Mesh:

Year:  2005        PMID: 16351478     DOI: 10.4321/s0212-71992005001000005

Source DB:  PubMed          Journal:  An Med Interna        ISSN: 0212-7199


  2 in total

1.  Burden of herpes simplex virus encephalitis in the United States.

Authors:  S Modi; Abhimanyu Mahajan; D Dharaiya; P Varelas; P Mitsias
Journal:  J Neurol       Date:  2017-05-17       Impact factor: 4.849

2.  Herpesvirus encephalitis diagnosed by polymerase chain reaction at the National Institute of Neurology of Mexico.

Authors:  Esperanza Garcia; Quetzalina Flores Fajardo; Rubén Figueroa; Víctor Chavarría; Arely Vergara Castañeda; Aleli Salazar; Verónica Pérez de la Cruz; Julio Sotelo; Benjamín Pineda
Journal:  J Neurovirol       Date:  2021-04-08       Impact factor: 2.643

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.